Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Electromed (ELMD)
:ELMD
ELMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.74 - $35.56
Previous CloseN/A
Volume34.94K
Average Volume (3M)111.34K
Market Cap
$252.85M
Enterprise Value$178.95M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)38.9
Beta0.46
Next Earnings
May 13, 2025EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.76
Shares Outstanding8,556,844
10 Day Avg. Volume155,356
30 Day Avg. Volume111,344
Standard Deviation0.13
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.21
Price to Cash Flow (P/CF)19.90
P/FCF Ratio19.30
Enterprise Value/Market Cap0.71
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.29
Enterprise Value/Ebitda19.72
Forecast
1Y Price Target
$37.00Price Target Upside29.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Electromed News
PremiumCompany Announcements
Electromed Soars with Record Revenues and Growth
PremiumCompany Announcements
Electromed Reports Record Growth in Q2 2025PremiumCompany Announcements
Electromed Reports Record Q2 2025 Financial Performance
PremiumCompany Announcements
Electromed Reports Strong Start to Fiscal 2025---
Bulls Say, Bears Say
Bulls Say
Financial HealthThe company has $16M in cash, $23M in accounts receivable, no debt, and is the final remaining pure-play in the HFCWO space, making it an attractive takeout target for a larger medtech strategy.
Management And OperationsThe new management team and board have accomplished growth through product enhancements, sales force productivity, leaner and more efficient reimbursement, market development efforts, and streamlined operations.
Bears Say
Market PenetrationAs the Company continues to gain traction in the underpenetrated bronchiectasis market, multiple expansion is warranted.
---
Options Prices
Currently, No data available
---
Ownership Overview
9.17% Insiders
8.84% Mutual Funds
12.80% Other Institutional Investors
63.57% Public Companies and Individual Investors
ELMD FAQ
What was Electromed’s price range in the past 12 months?
Electromed lowest stock price was $13.74 and its highest was $35.56 in the past 12 months.
What is Electromed’s market cap?
Electromed’s market cap is $252.85M.
When is Electromed’s upcoming earnings report date?
Electromed’s upcoming earnings report date is May 13, 2025 which is in 80 days.
How were Electromed’s earnings last quarter?
Electromed released its earnings results on Feb 11, 2025. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.04.
Is Electromed overvalued?
According to Wall Street analysts Electromed’s price is currently Undervalued.
Does Electromed pay dividends?
Electromed does not currently pay dividends.
What is Electromed’s EPS estimate?
Electromed’s EPS estimate is 0.2.
How many shares outstanding does Electromed have?
Electromed has 8,556,844 shares outstanding.
What happened to Electromed’s price movement after its last earnings report?
Electromed reported an EPS of $0.22 in its last earnings report, beating expectations of $0.18. Following the earnings report the stock price went up 13.973%.
Which hedge fund is a major shareholder of Electromed?
Currently, no hedge funds are holding shares in ELMD
---
Electromed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$37.00 (29.24% Upside)
$37.00 (29.24% Upside)
Blogger Sentiment
Bullish
ELMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $5.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.7%
Last 30 Days ▼ 8.8%
Last 30 Days ▼ 8.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
90.99%
12-Months-Change
Fundamentals
Return on Equity
16.11%
Trailing 12-Months
Asset Growth
11.31%
Trailing 12-Months
Company Description
Electromed
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. It offers smartvest, and airways clearance system to patients with compromised pulmonary function. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.
---
ELMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with record revenues, growth in multiple segments, and efficient financial management. While there were some increases in expenses and minor fluctuations in revenue, the overall outlook remains positive with continued growth and strategic investments.Read More>---
ELMD Stock 12 Month Forecast
Average Price Target
$37.00
▲(29.24% Upside)
Technical Analysis
ICU Medical
―
Luna Innovations
―
Tandem Diabetes Care
―
BioLife Solutions
―
Senseonics Holdings
―
Best Analysts Covering ELMD
1 Year
1 Year Success Rate
5/8 ratings generated profit
1 Year Average Return
+6.91%
initiated a buy rating 2 days ago
Copying Kyle Bauser's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +6.91% per trade.
---